MONOPAR THERAPEUTICS (MNPR) Social Stream



MONOPAR THERAPEUTICS (MNPR): $0.61

0.01 (-1.21%)

POWR Rating

Component Grades

Momentum

D

Stability

D

Sentiment

Quality

D

Add MNPR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#187 of 362

in industry

MONOPAR THERAPEUTICS (MNPR) Price Targets From Analysts

Use the tables below to see what analysts covering MONOPAR THERAPEUTICS think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-15 4 $49 $9 $32.666 $0.44 7324.09%
2022-02-16 3 $49 $9 $27.25 $0.44 6093.18%
2022-03-25 4 $49 $9 $27.25 $0.44 6093.18%
2022-05-16 4 $49 $8 $26.5 $0.44 5922.73%
2022-08-11 4 $40 $8 $18.75 $0.44 4161.36%
2022-10-05 4 $18 $5 $9.666 $0.44 2096.82%
2022-11-11 4 $40 $5 $17.25 $0.44 3820.45%
2023-01-09 4 $40 $6 $18 $0.44 3990.91%
2023-03-24 5 $40 $6 $19.2 $0.44 4263.64%
2023-03-28 5 $18 $6 $12.8 $0.44 2809.09%
2023-05-11 5 $17 $3 $10.25 $0.44 2229.55%
2023-05-15 5 $17 $2 $9.25 $0.44 2002.27%
2023-08-10 4 $17 $15 $16.333 $0.44 3612.05%
2023-11-10 3 $15 $2 $8.5 $0.44 1831.82%

The Trend in the Analyst Price Target


Over the past 32 months, MNPR's average price target has gone down $23.67.

MNPR reports an average of 1,593.76% for its upside potential over the past 42 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-08-10 5 17.000 15 16.333 0.749 2080.64%
2023-08-10 4 17.000 3 13.000 0.749 1635.65%
2023-11-10 3 17.000 2 11.333 0.369 2971.27%
2023-11-10 3 15.000 2 8.500 0.369 2203.52%
2023-11-10 3 17.001 2 11.333 0.369 2971.27%

MNPR Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.5 3 0 1 0 0 4

The Trend in the Broker Recommendations


Over the past 15 months, MNPR's average broker recommendation rating worsened by 0.67.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for MNPR as an investment opportunity.

  • MNPR has a greater upside potential (average analyst target price relative to current price) than 1787.41% of all US stocks.
  • MNPR has a lower variance in analysts' estimates than -1525.59% of all US stocks.
  • In terms of how MONOPAR THERAPEUTICS fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 329.38% of that group.
  • In the context of Healthcare stocks, MONOPAR THERAPEUTICS's average analyst price target is greater than 504.93% of them.

In the Pharmaceutical Products industry, CNSP, TRVI, and MREO are the three stocks most similar to MONOPAR THERAPEUTICS regarding the price target and analyst recommendation information presented here.

What is the outlook for MNPR? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!